![](/accounts/issx/images/logo.png)
Session 4: Interpretation and Application of LC-MS Proteomics Output
Co-Chairs: Sibylle Neuhoff, Certara, Sheffield, United Kingdom and Amin Rostami, University of Manchester, Manchester, United Kingdom
From in vitro to in vivo: A Long Road but Not Endless!
![image](https://0285ccf8d8d5a9b20200-3e169e2c0ff5fc72cbbca6def6c650ae.ssl.cf2.rackcdn.com/issx_8300d9b300fc72bb340c28d5d64e5f85.png)
Sibylle Neuhoff, Certara, Sheffield, United Kingdom
The Impact: Where We Are & Where We Are Heading to?
![image](https://0285ccf8d8d5a9b20200-3e169e2c0ff5fc72cbbca6def6c650ae.ssl.cf2.rackcdn.com/issx_366356234bec91640d010a1ea9bf88b9.png)
Amin Rostami, University of Manchester, Manchester, United Kingdom
Key:
![](/images/product-status-icons/complete-small.png)
![](/images/product-status-icons/next-small.png)
![](/images/product-status-icons/disabled-small.png)
![](/images/product-status-icons/optional-small.png)
![](/images/product-status-icons/locked-small.png)
Session 4: From in vitro to in vivo: A Long Road but Not Endless!
Recorded 06/27/2024 | 12 minutes
Recorded 06/27/2024 | 12 minutes
This session enabled the participants to widen their knowledge of applications beyond what they might have known and indicate examples of ongoing research which benefit from incorporation of LC-MS proteomic data in relation to drug development cases.
Session 4: The Impact: Where We Are & Where We Are Heading to?
Recorded 06/27/2024 | 28 minutes
Recorded 06/27/2024 | 28 minutes
This session enabled the participants to widen their knowledge of applications beyond what they might have known and indicate examples of ongoing research which benefit from incorporation of LC-MS proteomic data in relation to drug development cases.